insights_auto
Why is AVTX down ၉.၅၂%?
Dive Deeperchevron_right
AVTX:NASDAQ
Avalo Therapeutics Inc
၇.၇၀ US$
arrow_downward
-၉.၅၂%(-၀.၈၁) 1D
၇.၅၈ US$
arrow_downward
-၁.၅၆% (-၀.၁၂)bedtimeAfter hours
Closed: နို ၁၂, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVTX...
Open
၈.၂၉ US$
High
၈.၃၉ US$
Low
၇.၄၁ US$
Mkt. cap
၄၄.၅၂ ကုဋေ
Avg. vol.
၂.၄၇ သန်း
Volume
၂.၉၆ သန်း
52-wk high
၂၄.၂၇ US$
52-wk low
၆.၅၃ US$
EPS
-၂.၉၁ US$
Beta
၀.၇၅
Shares outstanding
၅.၇၈ ကုဋေ
No. of employees
၃၃
Open
၈.၂၉ US$
High
၈.၃၉ US$
Low
၇.၄၁ US$
Mkt. cap
၄၄.၅၂ ကုဋေ
Avg. vol.
၂.၄၇ သန်း
Volume
၂.၉၆ သန်း
52-wk high
၂၄.၂၇ US$
52-wk low
၆.၅၃ US$
EPS
-၂.၉၁ US$
Beta
၀.၇၅
Shares outstanding
၅.၇၈ ကုဋေ
No. of employees
၃၃
News stories
From web sources and news partners
Kalkine
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Avalo Therapeutics (NASDAQ:AVTX) Prepares Phase Three Programme as Abdakibart Development Moves Forward
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Here's Why Avalo Therapeutics (AVTX) is Poised for a Turnaround After Losing 40.4% in 4 Weeks
Investing.com Canada
·
ပြီးခဲ့သည့် ၂ ရက်
Avalo Therapeutics at Stifel 2026 Healthcare Conference: phase iii ahead By Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၃ ရက်
Avalo Therapeutics at Guggenheim conference: cash-rich, trial-focused
About Avalo Therapeutics Inc
CEO-
Employees၃၃
Founded၂၀၁၁
HeadquartersRockville, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websiteavalotx.com